Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)
Clinical trial NCT02702401 · COMPLETED
Trial details
- NCT number
- NCT02702401
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-26
- Primary completion
- 2019-01-02
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.